Clinical Trial Update: Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hypofractionated external radiotherapy with bevacizumab and temozolomide for recurrent gliomas; the study was terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Ependymoma
• Anaplastic Oligodendroglioma
• Glioblastoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)
• hypofractionated external radiotherapy

Snippet

Sponsor: Northwestern University | Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Phase 2 | Status: TERMINATED | Results posted: 2020-03-12